RxDoctor Payments Data

Michael Costanza, MD

Vascular Surgery · Syracuse, NYNPI 1679523542

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $31,750 of the $42,124 with a category attached, or 75.4%. Endologix LLC accounts for 64.7% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2020 at $9,397 and has fallen 52.7% since, to $4,441 in 2025.

$42,124in general payments, 2019–2025

Across 77 payments — averaging $547.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Endologix LLC$27K
  • Inari Medical, Inc.$9K
  • Silk Road Medical, Inc.$2K
  • W. L. Gore & Associates, Inc.$2K
  • Terumo Medical Corporation$664
  • Medtronic$241
  • plus $569 from 7 others
$1,175in research payments, 2019–2025

Across 2 payments — averaging $587.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bard Peripheral Vascular, Inc.$1K

What the payments were for

  • Consulting fees$31,75075%
  • Speaking & faculty fees$1,7504%
  • Travel & lodging$5,30313%
  • Food & beverage$3,3228%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$42,124 in reported general payments places this provider in the 85th percentile of 405 vascular surgery providers in New York.

See all vascular surgery providers in New York →

Medicare billing

Part B allowed, 2024
$178,619
Medicare patients
870
Services billed
1,312

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cilostazol26$674
ClopidogrelClopidogrel Bisulfate22$120
Gabapentin16$106

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Syracuse

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →